BP1270

奈韦拉平

British Pharmacopoeia (BP) Reference Standard

• 别名: 11-环丙基-5,11-二氢-4-甲基-6H-二吡啶基[3,2-b:2′,3′-e][1,4] 二氮杂- 6-酮
• 经验公式（希尔记法）: C₁₅H₁₄N₄O
• CAS号: 129618-40-2
• 分子量: 266.30
• MDL编号: MFCD00866928
• UNSPSC代码: 41116107
• NACRES: NA.24

属性

• 等级: pharmaceutical primary standard
• API类: nevirapine
• 表单: solid
• 保质期: limited shelf life, expiry date on the label
• 制造商/商品名称: BP
• 应用: pharmaceutical; pharmaceutical small molecule
• 包装形式: neat
• 储存温度: 2-8°C
• SMILES字符串: CC1=CC=NC2=C1NC(C(C=CC=N3)=C3N2C4CC4)=O
• InChI: 1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)
• InChI key: NQDJXKOVJZTUJA-UHFFFAOYSA-N

说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Nevirapine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Nevirapine Oral Suspension

生化/生理作用

HIV-1 的 NNRTI（非核苷类逆转录酶抑制剂）

奈韦拉平是 HIV 逆转录酶（NNRTI）的变构非核苷抑制剂。奈韦拉平抑制野生型 RT 的 K_i 为 200 nM。

包装

Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

安全信息

• 储存分类代码: 11 - Combustible Solids
• WGK: WGK 2
• 闪点(°F): Not applicable
• 闪点(°C): Not applicable